| Literature DB >> 35052999 |
Valentina Valenzuela-Muñoz1,2,3, Cristian Gallardo-Escárate1,3, Bárbara P Benavente1,3, Diego Valenzuela-Miranda1,3, Gustavo Núñez-Acuña1,3, Hugo Escobar-Sepulveda1,3, Juan Antonio Váldes1,2.
Abstract
The growing amount of genome information and transcriptomes data available allows for a better understanding of biological processes. However, analysis of complex transcriptomic experimental designs involving different conditions, tissues, or times is relevant. This study proposes a novel approach to analyze complex data sets combining transcriptomes and miRNAs at the chromosome-level genome. Atlantic salmon smolts were transferred to seawater under two strategies: (i) fish group exposed to gradual salinity changes (GSC) and (ii) fish group exposed to a salinity shock (SS). Gills, intestine, and head kidney samples were used for total RNA extraction, followed by mRNA and small RNA illumina sequencing. Different expression patterns among the tissues and treatments were observed through a whole-genome transcriptomic approach. Chromosome regions highly expressed between experimental conditions included a great abundance of transposable elements. In addition, differential expression analysis showed a greater number of transcripts modulated in response to SS in gills and head kidney. miRNA expression analysis suggested a small number of miRNAs involved in the smoltification process. However, target analysis of these miRNAs showed a regulatory role in growth, stress response, and immunity. This study is the first to evidence the interplaying among mRNAs and miRNAs and the structural relationship at the genome level during Atlantic salmon smoltification.Entities:
Keywords: Atlantic salmon; genome; mRNAs; miRNAs; smoltification
Year: 2021 PMID: 35052999 PMCID: PMC8772943 DOI: 10.3390/biology11010001
Source DB: PubMed Journal: Biology (Basel) ISSN: 2079-7737
Figure 1Whole-genome expression approach for transcriptome analysis during smoltification in Atlantic salmon.
Figure 2Whole-genome transcription of Atlantic salmon gills during smoltification process. (A) Threshold analysis of gills for GSC and SS fish groups. (B) Chromosome regions with high CGE index variation between GSC and SS fish groups. Heatmap in red shows the expression variation between both groups, CGE index. Black line graph indicates genome coverage of threshold areas. In the Circos plot, the ribbons represent the homoeologous regions in salmon genome. (C) RNA-Seq analysis of chromosome regions with high CGE index between experimental groups.
Figure 3Whole-genome transcription in Atlantic salmon intestine during smoltification process. (A) Threshold analysis of gills for GSC and SS fish groups. (B) Chromosome regions with high CGE index variation between GSC and SS fish groups. Heatmap in red shows the expression variation between both groups, CGE index. Black line graph indicates genome coverage of threshold areas. In the Circos plot, the ribbons represent the homoeologous regions in salmon genome. (C) RNA-Seq analysis of chromosomes regions with high CGE index between experimental groups.
Figure 4Whole-genome transcription in Atlantic salmon head kidney during smoltification process. (A) Threshold analysis of gills for GSC and SS fish groups. (B) Chromosome regions with high CGE index variation between GSC and SS fish groups. Heatmap in red shows the expression variation between both groups, CGE index. Black line graph indicates genome coverage of threshold areas. In the Circos plot, the ribbons represent the homoeologous regions in salmon genome. (C) RNA-Seq analysis of chromosome regions with high CGE index between experimental groups.
Figure 5Differential expression analysis and GO enrichment of Atlantic salmon exposed to GSC and SS. (A) DEGs and GO enrichment of gills tissue. (B) DEGs and GO enrichment of intestine tissue. (C) DEGs and GO enrichment of head kidney tissue.
Figure 6miRNA expression profile during gradual salinity changes and salinity shock in gills, intestine, and head kidney of Atlantic salmon.
Figure 7miRNA differential expression analysis of Atlantic salmon tissues under both conditions, GSC and SS. Tables show the fold-change values of miRNA for each tissue; red: upregulated, blue: downregulated.
GO enrichment analysis of differently modulated putative miRNA target genes in Atlantic salmon exposed to gradual salinity changes (GSC) and salinity shock (SS).
| GSC Atlantic Salmon | SS Atlantic Salmon | ||
|---|---|---|---|
| Gill Tissue Biological Process | N° GO Term | Gill Tissue Biological Process | N° GO Term |
| Cellular process | 269 | Pattern recognitio receptor signaling pathway | 126 |
| Metabolic prosess | 259 | Regulation of Pattern recognitio receptor signaling pathway | 121 |
| Response to stimilus | 243 | Truptophanil-tRNA aminoacylation | 59 |
| Macromolecule metabolic process | 241 | Protein ADP-ribosylation | 53 |
| Biological regulation | 239 | Regulation od protein ADP-ribosylation | 51 |
| Regulation of biological process | 234 | Spindle assembly | 43 |
| Cellular biosynthetic process | 233 | Mitotic spindle assembly | 32 |
| Regulation of cellular process | 232 | Response to ATP | 30 |
| Organic cyclic compound metabolic process | 229 | Regulation of meiotic cell cycle | 28 |
| Celullar response to stimulus | 226 | Microtube nucleation | 23 |
| Gene expression | 221 | Carbon utilization | 22 |
| Regulation of metabolic process | 218 | Regulation of mitotic spindle assembly | 20 |
| Localization | 215 | ||
| Cell communication | 214 | ||
| Transport | 212 | ||
| Organic ciclyc compound biosynthetic process | 210 | ||
| Regulation of cellular metabolic process | 210 | ||
| Cellular component organization | 209 | ||
| Cellular component organization or biogenesis | 209 | ||
| Portein metabolic process | 209 | ||
| Cellular macomolecule biosynthetic process | 208 | ||
| Response to stress | 203 | ||
| Immune system process | 202 | ||
| Small molecules metabolic process | 202 | ||
| Regulation of gene expression | 202 | ||
|
|
|
|
|
| Cellular process | 269 | Regulation of mononuclear cell proliferation | 8 |
| Metabolic prosess | 259 | Regulation of lymphocyte proliferation | 8 |
| Organic substance metabolic process | 256 | Antigen processing and presentation of peptide | 8 |
| Cellular metabolic process | 255 | Hydrogen peroxide catabolic process | 7 |
| Prymary metabolic process | 253 | Antigen processing and presentation of peptide antigen | 7 |
| Response to stimilus | 243 | MCH class II | 6 |
| Macromolecule metabolic process | 241 | Fertilization | 5 |
| Biological regulation | 239 | Cell-cell recognition | 4 |
| Organic substance biosynthetic process | 237 | Sperm-egg recognition | 3 |
| Biosynthetic process | 237 | Lung epithelium development | 3 |
| Regulation of biological process | 234 | Hemolysis in other organims | 3 |
| Cellular macomolecule metabolic process | 233 | Microtubule polymerization | 3 |
| Regulation of cellular process | 233 | Regulation of platelet activation | 3 |
| Cellular response to stimulus | 232 | Forebrain neuron differentation | 3 |
| Gene expression | 226 | Forebrain generation of neurons | 3 |
| Nucleobase-containing compund metabolic process | 221 | ||
| Regulation of metabolic process | 221 | ||
| Cellular nitrogen compound bisynthetic process | 218 | ||
| Localization | 215 | ||
| Cell communication | 214 | ||
| Transport | 212 | ||
| Response to stress | 203 | ||
| Immune system process | 202 | ||
| Regulation of gene expression | 202 | ||
|
|
|
|
|
| Cellular process | 169 | DNA integration | 82 |
| Metabolic prosess | 165 | Transposition | 55 |
| Cellular metabolic process | 163 | Transposition, DNA-mediated | 55 |
| Organic substance metabolic process | 163 | Macromolecule glycosylation | 42 |
| Primary metabolic process | 158 | Protein glycosilation | 42 |
| Nitrogen compund metabolic process | 154 | Pryrimidine nucleotide-sugar transmembrane transport | 19 |
| Cellular biosynthetic process | 153 | Nucelotide-sugar transmembrane transport | 19 |
| Biosyntetic process | 153 | ARF protein signal transduction | 10 |
| Organic substance biosynthetic process | 152 | Regulation of ARF protein signal transduction | 10 |
| Macromolecule metabolic process | 151 | ||
| Biological regulation | 149 | ||
| Organonitrogen compound metabolic process | 149 | ||
| Response to stimilus | 147 | ||
| Cellular macomolecule metabolic process | 147 | ||
| Regulation of biological process | 146 | ||
| Localization | 144 | ||
| Cellular nitrogen compound metabolic process | 143 | ||
| Regulation of cellular process | 143 | ||
| Organic cyclic compound metabolic process | 143 | ||
| Transport | 142 | ||
| Establishment of localization | 142 | ||
| Immune system process | 124 | ||
| Immune response | 119 | ||
| Defense response | 108 | ||
| Response to biotic stimilus | 103 | ||
Expression modulation of miRNAs and their putative target genes in Atlantic salmon exposed to GSC and SS.
| Tissue | miRNA | Fold Change GSC | Fold Change SS | Fold Change GSC | Fold Change SS | Delta G | Description | |
|---|---|---|---|---|---|---|---|---|
| Gills | ssa-miR-204-5p | −2, 52 | 0 | contig_33389 | 2, 14 | 0 | −12.00 | PREDICTED: serine/threonine-protein kinase WNK2-like isoform X2 [Salmo salar] |
| ssa-miR-19c-3-5p | 3, 04 | 0 | contig_41523 | −2, 29 | 0 | −12.00 | PREDICTED: heat shock 70 kDa protein 12B-like [Salmo salar] | |
| ssa-miR-214-5p | −1, 51 | 0 | contig_50634 | 2, 59 | 0 | −12.00 | PREDICTED: creatine kinase S-type, mitochondrial isoform X1 [Salmo salar] | |
| ssa-miR-214-5p | −1, 51 | 0 | contig_29197 | 2, 47 | 0 | −12.20 | PREDICTED: MAPK/MAK/MRK overlapping kinase-like isoform X1 [Salmo salar] | |
| ssa-miR-199a-3p | −1, 52 | 0 | contig_12464 | 2, 54 | 0 | −12.00 | PREDICTED: interleukin-20 receptor subunit beta-like [Salmo salar] | |
| ssa-miR-19c-3-5p | 3, 04 | 0 | contig_3735 | −2, 11 | 0 | −12.00 | PREDICTED: myosin light chain kinase, smooth muscle-like isoform X3 [Salmo salar] | |
| ssa-miR-456-5p | 0 | 8, 79 | contig_63289 | 0 | −3, 32 | −12.00 | PREDICTED: fibroblast growth factor 10-like [Salmo salar] | |
| ssa-miR-150-3p | 0 | −1, 6 | contig_15517 | 0 | 2, 02 | −12.10 | ATPase inhibitor, mitochondrial precursor [Salmo salar] | |
| ssa-miR-19d-5p | 0 | −2, 68 | contig_13064 | 0 | 2, 07 | −12.00 | ATP-binding cassette sub-family F member 2 [Salmo salar] | |
| ssa-miR-222b-5p | 0 | −1, 98 | contig_78633 | 0 | 3, 86 | −12.00 | transposase [Salmo salar] | |
| ssa-miR-204-5p | −2, 52 | 0 | contig_66355 | 2, 96 | 0 | −12.00 | transposase [Salmo salar] | |
| ssa-miR-18b-5p | 0 | 1, 56 | contig_19956 | 0 | −17, 31 | −12.00 | PREDICTED: haptoglobin-like [Salmo salar] | |
| ssa-miR-456-5p | 0 | 8, 79 | contig_9077 | 0 | −3, 2 | −12.00 | SPATA5 [Salmo salar] | |
| ssa-miR-456-5p | 0 | 8, 79 | contig_52147 | 0 | −2, 72 | −12.10 | PREDICTED: MAPK/MAK/MRK overlapping kinase-like isoform X3 [Salmo salar] | |
| ssa-miR-456-5p | 0 | 8, 79 | contig_32835 | 0 | −2, 64 | −12.00 | interleukin-17A/F3 [Salmo salar] | |
| Intestine | ssa-miR-25-3-5p | 4, 02 | 0 | contig_19100 | −2, 43 | 0 | −30.60 | PREDICTED: non-syndromic hearing impairment protein 5-like isoform X2 [Salmo salar] |
| ssa-miR-30a-3-3p | 0 | 2, 28 | contig_58533 | −3, 12 | 0 | −30.50 | PREDICTED: kynureninase-like [Salmo salar] | |
| ssa-miR-92b-3p | 0 | 1, 22 | contig_2303 | 2, 07 | 0 | −30.40 | PREDICTED: coronin-1B-like [Salmo salar] | |
| ssa-miR-214-5p | 0 | 1, 35 | contig_3322 | 2, 75 | 0 | −30.10 | PREDICTED: fibroblast growth factor receptor substrate 2-like [Salmo salar] | |
| ssa-miR-19c-5p | −2, 06 | 0 | contig_51580 | 3, 29 | 0 | −30.10 | PREDICTED: protein-tyrosine kinase 6-like [Salmo salar] | |
| ssa-miR-92a-5p | 3, 72 | 0 | contig_4409 | −4, 12 | 0 | −30.00 | PREDICTED: dihydropyrimidinase-related protein 4-like [Salmo salar] | |
| ssa-miR-125b-5p | 0 | 1, 26 | contig_4543 | 0 | −1, 97 | −29.80 | PREDICTED: low-density lipoprotein receptor-related protein 2-like [Salmo salar] | |
| ssa-miR-30a-3-3p | 0 | 2, 28 | contig_3114 | 0 | −1, 94 | −29.00 | PREDICTED: free fatty acid receptor 3-like [Salmo salar] | |
| ssa-miR-30a-3p | −1, 73 | 0 | contig_44524 | 2, 17 | 0 | −29.00 | PREDICTED: annexin A2-like [Salmo salar] | |
| ssa-miR-92a-5p | 3, 72 | 0 | contig_51439 | −3, 15 | 0 | −28.90 | PREDICTED: myosin heavy chain, fast skeletal muscle-like [Salmo salar] | |
| ssa-miR-15a-3p | 1, 72 | 0 | contig_9149 | −2, 1 | 0 | −28.40 | PREDICTED: annexin A2-like [Salmo salar] | |
| ssa-miR-140-3p | −1, 53 | 0 | contig_25304 | 4, 52 | 0 | −28.40 | PREDICTED: leucine-rich repeat-containing protein 58-like [Salmo salar] | |
| ssa-miR-456-3p | 3, 35 | 0 | contig_24874 | −1, 73 | 0 | −17.60 | PREDICTED: sialic acid-binding Ig-like lectin 5 [Salmo salar] | |
| ssa-let-7i-5p | 0 | 5, 51 | contig_66659 | 0 | −1, 37 | −16.80 | PREDICTED: dedicator of cytokinesis protein 3-like, partial [Salmo salar] | |
| ssa-let-7d-5p | 4 | 0 | contig_28976 | −5, 05 | 0 | −16.00 | PREDICTED: fibroblast growth factor receptor substrate 2-like [Salmo salar] | |
| Head kidney | ssa-miR-8157-3p | 0 | −2, 18 | contig_122554 | 0 | 6, 77 | −30.20 | PREDICTED: E3 ubiquitin-protein ligase TRIP12-like isoform X1 [Salmo salar] |
| ssa-miR-128-1-5p | −1, 57 | 0 | contig_72217 | 6, 3 | 0 | −29.60 | SPATA5 [Salmo salar] | |
| ssa-miR-214-3p | 0 | 1, 8 | contig_21752 | 0 | −1, 47 | −29.50 | PREDICTED: BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 isoform X1 [Salmo salar] | |
| ssa-miR-8157-3p | 0 | −2, 18 | contig_46746 | 0 | 1, 67 | −29.50 | PREDICTED: phospholipid-transporting ATPase 11C-like isoform X1 [Salmo salar] | |
| ssa-miR-205a-5p | 0 | 1, 99 | contig_45675 | 0 | −1, 03 | −29.40 | PREDICTED: von Willebrand factor A domain-containing protein 7-like [Salmo salar] | |
| ssa-miR-214-3p | 0 | 1, 8 | contig_95191 | 0 | −1, 84 | −28.90 | PREDICTED: fibrinogen beta chain-like [Salmo salar] | |
| ssa-miR-194a-3p | 7, 34 | 0 | contig_28663 | −3, 31 | 0 | −28.60 | PREDICTED: laminin subunit alpha-4-like isoform X1 [Salmo salar] | |
| ssa-miR-462a-3p | −1, 86 | 0 | contig_22955 | 2, 08 | 0 | −34.50 | PREDICTED: 3-keto-steroid reductase-like isoform X2 [Salmo salar] | |
| ssa-miR-122-5p | 0 | 3, 15 | contig_68369 | 0 | −1, 89 | −29.80 | PREDICTED: transcription factor E2F7-like [Salmo salar] | |
| ssa-miR-125a-5p | 0 | 2, 32 | contig_31191 | 0 | −1, 03 | −27.70 | PREDICTED: tectonic-2 [Salmo salar] | |
| ssa-miR-449a-5p | 21, 47 | 0 | contig_44769 | −2, 24 | 0 | −20.40 | PREDICTED: guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3-like isoform X1 [Salmo salar] | |
| ssa-miR-192b-5p | 13, 39 | 0 | contig_65873 | −2, 18 | 0 | −20.00 | PREDICTED: E3 ubiquitin-protein ligase RNF144A-like [Salmo salar] | |
| ssa-miR-212a-5p | −1, 83 | 0 | contig_49183 | 2, 56 | 0 | PREDICTED: collagen EMF1-alpha-like [Salmo salar] |
Figure 8Correlation analysis of expression pairs among smoltification-related genes, TEs, and differential expressed miRNAs. TPM values. Corrplot analyses were conducted on differentially expressed smoltification-related genes, TEs, and differential expressed miRNAs (fold change > |4| and p-value < 0.01) in the combination of all the data, including exposure to the three tissue and GSC and SS conditions. Only Pearson’s correlation values that were significant (p-value > 0.01) are shown in the plot. Red pies correspond to significant negative correlations, and blue pies correspond to significant positive correlations. The completeness of the pies corresponds to the correlation level, where pies closer to circular shape correspond to values more proximal to |1| in Pearson’s calculation.